DSL(SH:603233)2019-10-30 16:00Financial Performance - Net profit attributable to shareholders was ¥556,174,044.46, representing a year-on-year growth of 34.34%[5] - Operating income for the first nine months was ¥8,040,587,380.63, up 27.65% from the same period last year[5] - Total revenue for Q3 2019 reached RMB 2,788,167,735.80, a 25.8% increase from RMB 2,216,074,313.09 in Q3 2018[29] - Net profit for the first three quarters of 2019 was RMB 644,642,360.51, compared to RMB 466,388,846.64 in the same period of 2018, reflecting a significant growth[28] - The net profit attributable to shareholders for Q3 2019 was ¥175,459,723.78, compared to ¥126,025,248.56 in Q3 2018, reflecting a year-over-year increase of about 39.2%[33] - The company's net profit for the first nine months of 2019 was ¥551,790,350.73, compared to ¥409,703,515.54 for the same period in 2018, marking an increase of around 34.5%[35] Assets and Liabilities - Total assets at the end of the reporting period reached ¥7,909,617,289.47, an increase of 21.00% compared to the previous year[5] - The total liabilities of the company were approximately 4.33 billion RMB, an increase from 3.45 billion RMB year-on-year[23] - The company's total equity attributable to shareholders reached approximately 3.51 billion RMB, compared to 3.04 billion RMB in the previous year[24] - Total current liabilities were 3,414,114,393.67 RMB, indicating the company's short-term financial obligations[46] - Total non-current liabilities stood at 36,205,160.00 RMB, showing the company's long-term financial commitments[46] - The total liabilities of the company reached 3,450,319,553.67 RMB, highlighting the overall debt level[46] Cash Flow - Net cash flow from operating activities increased by 118.25% to ¥1,085,256,111.62 for the first nine months[5] - Cash flow from operating activities for the first three quarters of 2019 was ¥8.95 billion, an increase of 22.6% from ¥7.30 billion in the same period of 2018[39] - The net cash flow from operating activities for Q3 2019 was ¥1.09 billion, significantly up from ¥497.26 million in Q3 2018[40] - The company reported cash inflow from investment activities of ¥861.85 million, down from ¥2.53 billion in the previous year[40] - The net cash flow from financing activities was ¥586.65 million, compared to a net outflow of ¥147.95 million in the same period last year[41] Shareholder Information - The total number of shareholders at the end of the reporting period was 7,855[10] - Major shareholder Ke Jinlong holds 22.50% of the shares, with 12,233,000 shares pledged[10] Store Operations - As of September 30, 2019, the company operated a total of 4,256 stores, including 4,215 direct-operated stores and 41 franchised stores, with a net increase of 103 stores during the third quarter[15] - The company closed 16 stores during the quarter, mainly due to local planning and strategic adjustments[17] Acquisitions and Subsidiaries - The company accelerated its merger and acquisition activities, completing 2 industry-related acquisitions involving 94 stores during the reporting period[18] - The acquisition of 51% equity in Jixi Lingfeng Pharmacy Chain Co., Ltd. for a transfer price of 44.75 million RMB, which has 35 stores, is currently in process[18] - The company also acquired a total of 31.5% equity in Xi'an Kangxin Pharmacy Chain Co., Ltd. for a total transfer price of 34.01 million RMB, increasing its total stake to 51%[18] - The company established a wholly-owned subsidiary, Daclin Medical Health (Hainan) Co., Ltd., with a registered capital of 5 million RMB to enhance its healthcare service offerings[19] - Another wholly-owned subsidiary, Guangdong Daclin Pharmaceutical Technology Co., Ltd., was established with a registered capital of 30 million RMB to support regional health industry development[19] Financial Ratios and Metrics - The weighted average return on equity rose to 16.85%, an increase of 2.49 percentage points year-on-year[6] - Basic earnings per share were ¥1.07, reflecting a 3.88% increase compared to the previous year[6] - The basic earnings per share for Q3 2019 was ¥0.34, compared to ¥0.32 in Q3 2018, showing a growth of 6.25%[34] Inventory and Receivables - The company reported a significant decrease in accounts receivable notes, down 48.58% to CNY 2,762,080 from CNY 5,372,100 in the previous period[14] - Accounts receivable decreased to RMB 1,094,468,555.43 from RMB 1,219,447,168.49, indicating improved collection efficiency[27] - Inventory as of September 30, 2019, was approximately 1.98 billion RMB, compared to 1.89 billion RMB in the same period last year[22] - Inventory levels rose to RMB 709,145,022.85, up from RMB 679,589,069.76, suggesting potential stockpiling for future sales[27]